Skip to main content
OpenTrials
Completed

NCT Number: NCT01087372

Stress Hyperglycemia. Potential Role of Incretin Analogs

This is a prospective observational study to examine the levels of glucoregulatory hormones, with special focus on incretins levels, in critically ill patients with stress hyperglycemia.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hospital Universitari Son Dureta. Intensive Care Unit

Palma de Mallorca, Balearic Islands, 07014, Spain

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age > 18 years
  • Emergent ICU admission
  • Written informed consent from patient or relative.

Exclusion criteria

  • Previously known type I or type II diabetes.
  • Patients who received insulin or oral antidiabetic agents before ICU admission.
  • Malignancies.
  • Scheduled surgery
  • Patients receiving enteral or parenteral nutrition.
  • Inability to obtain informed consent.

Treatment and study plan

Primary outcomes

  1. Incretins plasmatic levels

    Time frame: 28 days

    28 days and ICU mortality

Secondary outcomes

  1. glucagon

    Time frame: 28 days

    28 days and ICU mortality

  2. insulin

    Time frame: 28 days

    28 days and ICU mortality

  3. cortisol

    Time frame: 28 days

    28 days and ICU mortality

  4. HOMA index

    Time frame: 28 days

    28 days and ICU mortality

Sponsors and collaborators

Lead sponsor

Hospital Universitari Son Dureta

Other

Collaborators

  • Fundació Mateu Orfila

Registry information

Official study title

Stress Hyperglycemia in Critically Ill Patients. Potential Role of Incretin Analogs. A Preliminary Study

Important dates

Study start
2010
Primary completion
2010
Study completion
2010
First posted
Mar 16, 2010
Registry last updated
Jun 8, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.